Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
Diaz-Mitoma F, Halperin SA, Tapiero B, Hoffenbach A, Zappacosta PS, Radley D, Bradshaw S, Martin JC, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Diaz-Mitoma F, et al. Among authors: hoffenbach a. Vaccine. 2011 Feb 1;29(6):1324-31. doi: 10.1016/j.vaccine.2010.11.053. Epub 2010 Dec 4. Vaccine. 2011. PMID: 21134456 Clinical Trial.
Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL. Halperin SA, et al. Among authors: hoffenbach a. Hum Vaccin. 2005 Nov-Dec;1(6):245-50. doi: 10.4161/hv.1.6.2377. Epub 2005 Nov 17. Hum Vaccin. 2005. PMID: 17012871 Clinical Trial.
Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Halperin SA, et al. Among authors: hoffenbach a. Vaccine. 2009 Apr 28;27(19):2540-7. doi: 10.1016/j.vaccine.2008.11.115. Epub 2009 Jan 3. Vaccine. 2009. PMID: 19124057 Clinical Trial.
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Mallet E, Belohradsky BH, Lagos R, Gothefors L, Camier P, Carrière JP, Kanra G, Hoffenbach A, Langue J, Undreiner F, Roussel F, Reinert P, Flodmark CE, Stojanov S, Liese J, Levine MM, Muñoz A, Schödel F, Hessel L; Hexavalent Vaccine Trial Study Group. Mallet E, et al. Among authors: hoffenbach a. Vaccine. 2004 Mar 29;22(11-12):1343-57. doi: 10.1016/j.vaccine.2003.09.039. Vaccine. 2004. PMID: 15063556 Review.
New acellular pertussis-containing paediatric combined vaccines.
Pines E, Barrand M, Fabre P, Salomon H, Blondeau C, Wood SC, Hoffenbach A. Pines E, et al. Among authors: hoffenbach a. Vaccine. 1999 Mar 26;17(13-14):1650-6. doi: 10.1016/s0264-410x(98)00422-8. Vaccine. 1999. PMID: 10194818 Review.
Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age.
Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granström M, Blondeau C, Hoffenbach A. Carlsson RM, et al. Among authors: hoffenbach a. Pediatr Infect Dis J. 1998 Nov;17(11):1026-33. doi: 10.1097/00006454-199811000-00013. Pediatr Infect Dis J. 1998. PMID: 9849987 Clinical Trial.
Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age.
Lagos R, Hoffenbach A, Scemama M, Dupuy M, Schodel F, Hessel L, Levine M. Lagos R, et al. Among authors: hoffenbach a. Hum Vaccin. 2005 May-Jun;1(3):112-7. doi: 10.4161/hv.1.3.1848. Epub 2005 May 9. Hum Vaccin. 2005. PMID: 17012870 Clinical Trial.
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Lagos R, et al. Among authors: hoffenbach a. Pediatr Infect Dis J. 1998 Apr;17(4):294-304. doi: 10.1097/00006454-199804000-00006. Pediatr Infect Dis J. 1998. PMID: 9576383 Clinical Trial.
40 results